CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.42
-2.84 (-5.23%)
At close: Oct 30, 2026, 4:00 PM EDT
51.54
+0.12 (0.23%)
After-hours: Oct 30, 2026, 7:57 PM EDT
CRISPR Therapeutics AG Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $45 | Hold | Maintains | $45 | -12.49% | Oct 21, 2026 |
| UBS | UBS | Hold Initiates $52 | Hold | Initiates | $52 | +1.13% | Oct 14, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $82 → $81 | Buy | Maintains | $82 → $81 | +57.53% | Oct 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $80 | Buy | Reiterates | $80 | +55.58% | Oct 9, 2026 |
| Needham | Needham | Buy Maintains $82 | Buy | Maintains | $82 | +59.47% | Oct 5, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $75 | Hold | Maintains | $75 | +45.86% | Oct 2, 2026 |
| Citi | Citi | Buy Maintains $88 | Buy | Maintains | $88 | +71.14% | Sep 4, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $76 | Buy | Maintains | $76 | +47.80% | Aug 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.